The status of Her2 amplification and Kras mutations in mucinous ovarian carcinoma.

Chang, Kuang-Leei; Lee, Ming-Yung; Chao, Wan-Ru; Han, Chih-Ping

Chang, Kuang-Leei; Lee, Ming-Yung; Chao, Wan-Ru; Han, Chih-Ping.

Afiliação

Chang KL; Department of Emergency Medicine, Chung-Shan Medical University and Chung Shan Medical University Hospital, Taichung, Taiwan.
Lee MY; Department of Statistics and Informatics Science, Providence University, Taichung, Taiwan.
Chao WR; Department of Pathology, Chung-Shan Medical University and Chung Shan Medical University Hospital, Taichung, Taiwan. y1034@csmu.edu.tw.
Han CP; Department of Pathology, Chung-Shan Medical University and Chung Shan Medical University Hospital, Taichung, Taiwan. cshy762@csh.org.tw.

Hum Genomics ; 10(1): 40, 2016 12 28.

Article em En | MEDLINE | ID: mdl-28031051

Assuntos

Adenocarcinoma Mucinoso; Carcinoma Epitelial do Ovário; Neoplasias Ovarianas; Feminino; Humanos; Mutação; Proteínas Proto-Oncogênicas p21(ras)

Palavras-chave

Her2 amplification; Kras mutation; Mucinous ovarian carcinoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Adenocarcinoma Mucinoso / Carcinoma Epitelial do Ovário Limite: Female / Humans Idioma: En Revista: Hum Genomics Assunto da revista: GENETICA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Taiwan

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google